Business Brief (July 22): China Pledges $3 Billion to Upgrade Freight Trucks

Published: Jul. 22, 2026 6:45 p.m. GMT+8

00:00

00:00/00:00

Listen to this article 1x

China’s National Medical Products Administration has approved a first-in-class drug targeting type 1 narcolepsy in adults and adolescents 16 and older.

The drug, which improves symptoms of excessive daytime sleepiness and cataplexy, marks a breakthrough for a globally innovative drug launched first in China. It has also been filed in the U.S., Japan and Europe.

News summary

Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.

Save an extra $50. Introductory offer for new readers. Subscribe now.

Share this article

Open WeChat and scan the QR code